Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIDENT: Intensive vs Standard Adalimumab for Crohn's Strictures
NCT03220841Phase 4Unknown
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Oct 2017
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, sponsored by St Vincent's Hospital Melbourne. Status: unknown.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03220841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220841.